Firefly Neuroscience Inc.
AIFF | NASDAQ
$1.24
+$0.01 (+0.81%)
Sep 22, 2026, 1:07 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.14M | 108K | 498K | n/a | 32K | 13.9M |
Cost of Revenue | 497K | 67K | n/a | n/a | n/a | 11.69M |
Gross Profit | 645K | 41K | 498K | n/a | 32K | 2.21M |
Operating Income | -8.61M | -9.18M | -3.08M | -3.33M | -4.65M | 411.85K |
Interest Income | 89K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -19.88M | -10.46M | -2.6M | -3.79M | -4.38M | 413.38K |
Net Income | -19.88M | -10.46M | -2.6M | -3.79M | -4.38M | 413.38K |
Selling & General & Admin | 7.77M | 7.33M | 2.84M | 1.98M | 1.68M | 1.8M |
Research & Development | 1.48M | 1.95M | 741K | 1.27M | 2.93M | n/a |
Other Expenses | n/a | -67K | n/a | 77K | 79K | n/a |
Operating Expenses | 9.25M | 9.22M | 3.58M | 3.33M | 4.69M | 1.8M |
Interest Expense | 159K | 69K | 18K | 574K | 135K | n/a |
Selling & Marketing Expenses | 800K | 1.2M | 639K | 65K | 20K | n/a |
Cost & Expenses | 9.75M | 9.29M | 3.58M | 3.33M | 4.69M | 13.49M |
Income Tax Expense | 5K | 2K | 1K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 13.2M | 6.55M | 7.87M | 7.87M | 7.87M | 7.87M |
Shares Outstanding (Diluted) | 13.5M | 6.55M | 7.87M | 7.87M | 7.87M | 7.87M |
EPS (Basic) | -1.86 | -1.60 | -0.33 | -0.48 | -0.56 | 0.05 |
EPS (Diluted) | -1.82 | -1.60 | -0.33 | -0.48 | -0.56 | 0.05 |
EBITDA | -19.55M | -10.32M | -2.58M | -3.2M | -3.82M | 425.44K |
EBIT | -19.72M | -10.39M | -2.58M | -3.22M | -4.25M | 413.38K |
Depreciation & Amortization | 172K | 67K | n/a | 14K | 429K | 12.06K |
Add to Watchlist
Select watchlists to add or remove AIFF